Roivant Sciences (ROIV) Income towards Parent Company (2020 - 2026)

Roivant Sciences (ROIV) has 5 years of Income towards Parent Company data on file, last reported at $373.2 million in Q4 2024.

• Quarterly Income towards Parent Company rose 264.66% year-over-year to $373.2 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $373.2 million (up 306.6% YoY) and the FY2025 annual result came in at $373.2 million, up 218.42% from the prior year.
• Income towards Parent Company grew to $373.2 million in Q4 2024, from -$43.1 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $373.2 million in Q4 2024 to a low of -$1.1 billion in Q4 2022.
• A 5-year average of -$216.2 million and a median of -$225.6 million in 2021 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2021 — Income towards Parent Company tumbled 1167.12% — and 2024, when it surged 264.66%.
• Tracing ROIV's Income towards Parent Company over 5 years: stood at -$275.6 million in 2020, then slumped by 129.61% to -$632.8 million in 2021, then tumbled by 66.66% to -$1.1 billion in 2022, then surged by 78.51% to -$226.6 million in 2023, then surged by 264.66% to $373.2 million in 2024.
• The last three Income towards Parent Company figures came in at $373.2 million (Q4 2024), -$43.1 million (Q3 2024), and $89.1 million (Q2 2024), per Business Quant data.